Singapore 2021 – ISCP Annual Meeting

Highlights from the 2021 Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy, in Singapore

Opening Session:
Poised to take over the world of Heart Failure Management

DM management in CVD:
Don’t throw the baby out with the bathwater – Should we still use sulphonylureas for patients with CVD?

Inflammation and atherosclerosis – the missing therapeutic link

Opening Plenary:
Cardiovascular implications of COVID-19

Interventional Pharmacology:
Walking the tightrope of ischemia and bleeding

The role of telemedicine and cardiovascular pharmacotherapy

Henry N. Neufeld lecture 2021:
Atrial fibrillation – What does the future hold?

Contemporary role of pharmacists as CV team members

Precision medicine in the use of antithrombotics: fact or fiction?

Stroke prevention in atrial fibrillation: the whole person

When your atria persist in fibrillation

Clinical pharmacotherapy in hypercholesterolemia: Targeting the bad, not forgetting the ugly

Oral presentation competition

How should SGLT2i be deployed in heart failure and renal patients – for everyone?

Hypertension updates: the low-down on the pressures that clinicians face

Closing plenary: Pharmacotherapy decision-making: Does the Asian paradox exist?